TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+3.73%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.92%)
Cap. Flow
+$26.2M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
206
New
17
Increased
43
Reduced
39
Closed
34
Top Buys
| 1 |
Rallybio
RLYB
|
$37.6M |
| 2 |
Guardant Health
GH
|
$28.7M |
| 3 |
Idexx Laboratories
IDXX
|
$27.9M |
| 4 |
Amgen
AMGN
|
$23.7M |
| 5 |
AstraZeneca
AZN
|
$21.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$34.7M |
| 2 |
ResMed
RMD
|
$32.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$22.2M |
| 4 |
DexCom
DXCM
|
$21.8M |
| 5 |
Ascendis Pharma
ASND
|
$13.7M |
Sector Composition
| 1 | Healthcare | 96.51% |
| 2 | Real Estate | 2.72% |
| 3 | Industrials | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIL
201
DELISTED
Trillium Therapeutics Inc.
TRIL
| – | – |
-529,226
| Closed | -$5.13M |
|
|
SNR
202
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| – | – |
-256,398
| Closed | -$2.25M |
|
|
ALXN
203
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-64,453
| Closed | -$11.8M |
|
|
PRAH
204
DELISTED
PRA Health Sciences, Inc.
PRAH
| – | – |
-25,068
| Closed | -$4.14M |
|
205
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-188,767
| Closed | -$11.5M |
|